Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors
Lei Zhou(Io Therapeutics (United States)), Laura Bohn(Scripps Research Institute), Stephen R. Slauson(University of Kansas), Cullen L. Schmid(Biogen (United States)), Thomas E. Prisinzano(University of Kentucky), Michael D. Cameron(Io Therapeutics (United States)), John M. Streicher(University of Arizona), Franck Madoux(Scripps Research Institute), Edward L. Stahl(University of South Florida), Angela M. Phillips(Harvard University), Kevin J. Frankowski(University of Kansas), Jeffrey Aubé(University of North Carolina at Chapel Hill), Peter Hodder(Scripps Research Institute), Kimberly M. Lovell(Io Therapeutics (United States))
Cited by 148
Related Papers
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
|Frontiers in Neuroendocrinology|2002|485
Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice.
|PubMed|2002|268
Differential Mechanisms of Morphine Antinociceptive Tolerance Revealed in βArrestin-2 Knock-Out Mice
|Journal of Neuroscience|2002|243
Serotonin, But Not <i>N</i> -Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex <i>In Vivo</i>
|Journal of Neuroscience|2010|171
Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons
|Proceedings of the National Academy of Sciences|2003|149